Clinical Features of Patients with HCC who are Negative for both HBV and HCV Markers

Hepato-Gastroenterology

Volumn 50, Issue 54, 2003, Pages 2157-2160

  Watabe, Hirotsugu ^a   Shiratori, Yasushi ^a   Tateishi, Ryousuke ^a   Fujishima, Tomonori ^a   Akamatsu, Masatoshi ^a   Koike, Yukihiro ^a   Obi, Shuntaro ^a   Hamamura, Keisuke ^a   Sato, Shinpei ^a   Teratani, Takuma ^a   Shiina, Shuichiro ^a   Omata, Masao ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Alcohol; Antibody to the hepatitis B core antigen; Cirrhosis; Hepatitis B; Hepatitis C; Hepatocellular carcinoma; Liver function

Indexed keywords

ADULT; AGED; ALCOHOLISM; ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE CLASSIFICATION; FEMALE; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INCIDENCE; LIVER FUNCTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADULT; AGED; BIOPSY, NEEDLE; CARCINOMA, HEPATOCELLULAR; DIAGNOSTIC IMAGING; FEMALE; FOLLOW-UP STUDIES; HEPATITIS B ANTIBODIES; HEPATITIS B CORE ANTIGENS; HEPATITIS B, CHRONIC; HEPATITIS C, CHRONIC; HEPATITIS, VIRAL, HUMAN; HUMANS; JAPAN; LIVER; LIVER CIRRHOSIS, ALCOHOLIC; LIVER FUNCTION TESTS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 10744229396     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Everhart JE: Digestive diseases in the United States: epidemiology and impact. 1994; NIH Publication No. 94-1447:227-245.
2. Parkin DM, Laara E, Muir CS: Estimates of the worldwide frequency of sixteen major cancers in 1980. Int J Cancer 1988; 41:184-197.
3. Tong MJ, Sun SC, Schaeffer BT, Chang NK, Lo KJ, Peters RL: Hepatitis-associated antigen and hepatocellular carcinoma in Taiwan. Ann Intern Med 1971; 75:687-691.
4. Bruix J, Barrera JM, Calvet X, et al: Prevalence of antibodies to hepatitis C virus in Spanish patients with hepatocellular carcinoma and hepatic cirrhosis. Lancet 1989; 2(8670):1004-1006.
5. Van Rensburg SJ, Cook-Mozarfari P, Van Schalkwyk DJ, Van der Watt JJ, Vincent TJ, Purchase IF: Hepatocellular carcinoma and dietary aflatoxin in Mozambique and Transkei. Br J Cancer 1985; 51:713-726.
6. Shiratori Y, Shiina S, Imamura M, et al: Characteristic difference of hepatocellular carcinoma between hepatitis B-and C-viral infection in Japan. Hepatology 1995; 22:1027-1033.
7. Nishioka K, Watanabe J, Furuta S, et al: A high prevalence of antibody to the hepatitis C virus in patients with hepatocellular carcinoma in Japan. Cancer 1991; 67:429-433.
8. Kew MC, Houston M, Choo QL, Kuo G: Hepatitis C virus antibodies in southern African blacks with hepatocellular carcinoma. Lancet 1990; 335:873-874.
9. Tong MJ, El-Farra NS, Reikes AR, Co RL: Clinical outcomes after transfusion-associated hepatitis C. N Engl J Med 1995; 332:1463-1466.
10. De Mitri MS, Poussin K, Baccarini P, et al: HCV-associated liver cancer without cirrhosis. Lancet 1995; 345:413-415.
11. Beasley RP, Hwang LY, Lin CC, Chien CS: Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22707 men in Taiwan. Lancet 1981; 2(8256):1129-1133.
12. Shafritz DA, Shouval D, Sherman HI, Hadziyannis SJ, Kew MC: Integration of hepatitis B virus DNA into the genome of liver cells in chronic liver disease and hepatocellular carcinoma. Studies in percutaneous liver biopsies and postmortem tissue specimens. N Engl J Med 1981; 305:1067-1073.
13. Tsukuma H, Hiyama T, Tanaka S, et al: Risk factors for hepatocellular carcinoma among patients with chronic liver disease. N Engl J Med 1993; 328:1797-1801.
14. Edmondson HA, Steiner PE: Primary carcinoma of the liver. A study of 100 cases among 48900 necropsies. Cancer 1954; 7:462-503.
15. Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Sheuer PJ: Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology 1994; 19:1513-1520.
16. Sheu JC, Huang GT, Shih LN, et al: Hepatitis C and B viruses in hepatitis B surface antigen-negative hepatocellular carcinoma. Gastroenterology 1992; 103:1322-1327.
17. Dickson RC, Everhart JE, Lake JR, et al: Transmission of hepatitis B by transplantation of livers from donors positive for antibody to hepatitis B core antigen. Gastroenterology 1997; 113:1668-1674.
18. Marusawa H, Uemoto S, Hijikata M, et al: Latent hepatitis B virus infection in healthy individuals with antibodies to hepatitis B core antigen. Hepatology 2000; 31:488-495.
19. Noguchi K, Nakashima O, Nakashima Y, Shiota K, Nawata H, Kojiro M: Clinicopathologic study on hepatocellular carcinoma negative for hepatitis B surface antigen and antibody to hepatitis C virus. Int J Mol Med 2000; 6:661-665.
20. Shiraishi M, Hiroyasu S, Nagahama M, et al: Characteristics of hepatocellular carcinoma in patients with negative virus markers: clinicopathologic study of resected tumors. World J Surg 1999; 23:301-305.